
Digital Biology builds a precision measurement platform that accelerates drug discovery by measuring and modifying cellular functions. The company combines molecular engineering, DNA nanotechnology, tissue biology, and spatial functional assays to map biological interactions in their native context and enable high-throughput functional screening of genetically encoded systems. Its platform includes machine learning and software for data analysis, visualization, and interpretation to support experimental workflows. Digital Biology partners with pharmaceutical and biotechnology companies to screen, characterize, and optimize therapeutic interactions directly within biological systems.

Digital Biology builds a precision measurement platform that accelerates drug discovery by measuring and modifying cellular functions. The company combines molecular engineering, DNA nanotechnology, tissue biology, and spatial functional assays to map biological interactions in their native context and enable high-throughput functional screening of genetically encoded systems. Its platform includes machine learning and software for data analysis, visualization, and interpretation to support experimental workflows. Digital Biology partners with pharmaceutical and biotechnology companies to screen, characterize, and optimize therapeutic interactions directly within biological systems.
Founded: 2022
Headquarters: Watertown, Massachusetts
Stage: Pre-Seed
Employees: 19
Core platform: M×P (Molecules × Phenotypes): imaging + NGS + computation + AI lab automation
Investors: Twine Ventures; SALT Fund; Not Boring
Target discovery, sequence-to-function screening, and translational tissue models (precision oncology / solid tumors); functional screening and characterization of genetically encoded systems within biological systems.
2022
Biotechnology
Pre-Seed round announced Jan 1, 2022; amount not publicly displayed in referenced sources.
“Twine Ventures; SALT Fund; Not Boring”